» Articles » PMID: 11696247

Beta1 Integrins Show Specific Association with CD98 Protein in Low Density Membranes

Overview
Journal BMC Biochem
Publisher Biomed Central
Specialty Biochemistry
Date 2001 Nov 7
PMID 11696247
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The CD98 (4F2, FRP-1) is a widely expressed cell surface protein heterodimer composed of a glycosylated heavy chain and a non-glycosylated light chain. Originally described as a T cell activation antigen, it was later shown to function in amino acid transport, cell fusion and homotypic cell aggregation. Several lines of evidence suggest its functional interaction with integrins but the biochemical basis for this interaction has been unclear.

Results: We demonstrate that CD98 constitutively and specifically associates with beta1 integrins (alpha2beta1,alpha3beta1, alpha5beta1 and alpha6beta1), but minimally with alpha4beta1. Integrin-CD98 association was established by reciprocal immunoprecipitation experiments, and confirmed by CD98-induced clustering of alpha3beta1 but not alpha4beta1 on the surface of rhabdomyosarcoma cells. Integrin-CD98 association is independent of the alpha subunit cytoplasmic tail, is maintained in alpha3beta1 ligand-interaction deficient mutants, and is not inhibited by EDTA. Within the CD98 heavy chain, a C109S mutation (but not a C330S mutation) caused a loss of beta1 integrin association. The same C109S mutation also caused a loss of CD98 light chain association. Importantly, CD98 associated selectively with beta1 integrins present in low density "light membrane" fractions on a sucrose gradient. CD98 was not present in dense fractions that contained the majority of beta1 integrins. Notably, the C109S mutant of CD98, that did not associate with beta1 integrins, showed also a reduced localization into light membrane fractions.

Conclusions: We demonstrate that CD98 association with beta1 integrins is specific, occurs in the context of low density membranes, and may require the CD98 light chain.

Citing Articles

Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.

Piniella D, Martinez-Blanco E, Bartolome-Martin D, Sanz-Martos A, Zafra F Cell Mol Life Sci. 2021; 78(23):7733-7756.

PMID: 34709416 PMC: 8629785. DOI: 10.1007/s00018-021-03998-1.


The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.

Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K Sci Rep. 2021; 11(1):11478.

PMID: 34075107 PMC: 8169706. DOI: 10.1038/s41598-021-90748-9.


Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Fairweather S, Shah N, Brer S Adv Exp Med Biol. 2020; 21:13-127.

PMID: 33052588 DOI: 10.1007/5584_2020_584.


Molecular mapping of transmembrane mechanotransduction through the β1 integrin-CD98hc-TRPV4 axis.

Potla R, Hirano-Kobayashi M, Wu H, Chen H, Mammoto A, Matthews B J Cell Sci. 2020; 133(20).

PMID: 32989042 PMC: 7657480. DOI: 10.1242/jcs.248823.


Overexpression of CD98 in intestinal epithelium dysregulates miRNAs and their targeted proteins along the ileal villus-crypt axis.

Han M, Baker M, Zhang Y, Yang C, Zhang M, Garg P Sci Rep. 2018; 8(1):16220.

PMID: 30385787 PMC: 6212412. DOI: 10.1038/s41598-018-34474-9.


References
1.
Sargiacomo M, Sudol M, Tang Z, Lisanti M . Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol. 1993; 122(4):789-807. PMC: 2119592. DOI: 10.1083/jcb.122.4.789. View

2.
Berditchevski F, Zutter M, Hemler M . Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol Biol Cell. 1996; 7(2):193-207. PMC: 275873. DOI: 10.1091/mbc.7.2.193. View

3.
Freidman A, Diaz Jr L, Moore S, Schaller J, Fox D . The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol. 1994; 154(1):253-63. DOI: 10.1006/cimm.1994.1075. View

4.
Ohta H, Tsurudome M, Matsumura H, Koga Y, Morikawa S, Kawano M . Molecular and biological characterization of fusion regulatory proteins (FRPs): anti-FRP mAbs induced HIV-mediated cell fusion via an integrin system. EMBO J. 1994; 13(9):2044-55. PMC: 395054. DOI: 10.1002/j.1460-2075.1994.tb06479.x. View

5.
Tabata N, Ito M, Shimokata K, Suga S, Ohgimoto S, Tsurudome M . Expression of fusion regulatory proteins (FRPs) on human peripheral blood monocytes. Induction of homotypic cell aggregation and formation of multinucleated giant cells by anti-FRP-1 monoclonal antibodies. J Immunol. 1994; 153(7):3256-66. View